Ekttitab Holding Company K.S.C Public (DFM:EKTTITAB)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions AED. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	83	57	66	40	82	58
Market Cap Growth	-12.80%	-12.47%	65.14%	-51.76%	41.54%	0.32%
Enterprise Value	83	57	65	38	79	53
Last Close Price	0.27	0.18	0.21	0.12	0.22	0.19
PS Ratio	7121.44	-3.21	7611.58	-966.37	119.23	151.23
PB Ratio	6.10	3.66	0.58	0.34	0.68	0.37
P/TBV Ratio	5.99	3.60	0.58	0.34	0.68	0.37
P/FCF Ratio	-	-	-	-	9.01	1.83
P/OCF Ratio	-	-	-	-	9.01	1.83
EV/Sales Ratio	-	-	7499.98	-	115.18	137.15
EV/FCF Ratio	-	-	-	-	8.70	1.66
Asset Turnover	0.00	-	0	-	0.00	0.00
Quick Ratio	0.01	0.08	2.76	3.24	1.29	9.44
Current Ratio	0.01	0.09	2.77	3.32	1.29	9.57
Return on Equity (ROE)	-9.87%	-50.32%	-1.65%	-1.10%	-16.48%	-6.93%
Return on Assets (ROA)	-4.32%	-28.82%	-0.99%	-0.57%	-8.79%	-4.69%
Return on Capital (ROIC)	-6.17%	-31.45%	-1.03%	-0.69%	-10.30%	-5.10%
Earnings Yield	-1.78%	-56.14%	-2.88%	-3.26%	-28.06%	-18.94%
FCF Yield	-	-0.16%	-7.47%	-37.31%	11.10%	54.76%
Buyback Yield / Dilution	0.85%	0.99%	-0.98%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.